Mirae Asset Global Investments Co. Ltd. Increases Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Mirae Asset Global Investments Co. Ltd. lifted its position in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 4.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 25,036 shares of the company’s stock after purchasing an additional 1,024 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Prestige Consumer Healthcare were worth $1,533,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Altshuler Shaham Ltd bought a new position in shares of Prestige Consumer Healthcare during the fourth quarter worth $27,000. Pacer Advisors Inc. boosted its position in shares of Prestige Consumer Healthcare by 85.7% during the fourth quarter. Pacer Advisors Inc. now owns 442 shares of the company’s stock worth $27,000 after acquiring an additional 204 shares during the last quarter. Provence Wealth Management Group bought a new position in shares of Prestige Consumer Healthcare during the third quarter worth $26,000. Natixis bought a new position in shares of Prestige Consumer Healthcare during the fourth quarter worth $36,000. Finally, International Assets Investment Management LLC boosted its position in shares of Prestige Consumer Healthcare by 1,900.0% during the fourth quarter. International Assets Investment Management LLC now owns 980 shares of the company’s stock worth $60,000 after acquiring an additional 931 shares during the last quarter. 99.95% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms have commented on PBH. StockNews.com upgraded shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, February 10th. TheStreet upgraded shares of Prestige Consumer Healthcare from a “c+” rating to a “b-” rating in a research report on Monday, February 12th. One equities research analyst has rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, Prestige Consumer Healthcare presently has a consensus rating of “Moderate Buy” and an average target price of $110.00.

Insider Activity

In other news, SVP Mary Beth Fritz sold 5,336 shares of the stock in a transaction on Thursday, February 8th. The shares were sold at an average price of $69.00, for a total value of $368,184.00. Following the sale, the senior vice president now owns 15,934 shares of the company’s stock, valued at $1,099,446. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 1.60% of the company’s stock.

Prestige Consumer Healthcare Price Performance

PBH stock opened at $69.67 on Monday. Prestige Consumer Healthcare Inc. has a 52 week low of $55.96 and a 52 week high of $75.31. The company has a quick ratio of 1.92, a current ratio of 3.09 and a debt-to-equity ratio of 0.75. The company has a fifty day simple moving average of $70.70 and a two-hundred day simple moving average of $63.86. The firm has a market capitalization of $3.46 billion, a P/E ratio of -42.48, a price-to-earnings-growth ratio of 1.89 and a beta of 0.52.

Prestige Consumer Healthcare (NYSE:PBH) last announced its earnings results on Thursday, February 8th. The company reported $1.06 earnings per share for the quarter, beating the consensus estimate of $1.04 by $0.02. Prestige Consumer Healthcare had a negative net margin of 7.11% and a positive return on equity of 14.09%. The business had revenue of $282.74 million for the quarter, compared to the consensus estimate of $280.25 million. During the same quarter in the prior year, the firm posted $1.04 earnings per share. The business’s revenue for the quarter was up 2.6% on a year-over-year basis. Analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.33 earnings per share for the current fiscal year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.